Omega 3 for Treatment of Depression in Patients With Heart Failure

PHASE3CompletedINTERVENTIONAL

Enrollment

108

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

May 19, 2016

Study Completion Date

December 2, 2016

Conditions

Depression

Interventions

DRUG

2:1 EPA/DHA

400 Eicosapentaenoic acid/200 docosahexaenoic acid fish oil 2 grams

DRUG

High EPA

OTHER

Placebo

Trial Locations (3)

Thomas Jefferson University, Philadelphia

University of North Carolina at Chapel Hill, Chapel Hill

Duke University Medical Center, Durham

All Listed Sponsors

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Wei Jiang

OTHER

NCT02057406 - Omega 3 for Treatment of Depression in Patients With Heart Failure | Biotech Hunter | Biotech Hunter